由于肺动脉衰变引起的严重血栓塞,约有两例罕见但具有威胁性的病例报告
Marina Gueçamburu1, Anne-Claire Toublanc1, Michel Montaudon2,3
1Service Des Maladies Respiratoires, Hôpital Haut Leveque CHU de Bordeaux Pessac France.
Respirology case reports
|April 28, 2025
概括
单侧肺动脉产生病变 (UPAA) 可以导致严重的,危及生命的血栓塞. 管理需要多学科的方法,通常涉及手术,特别是当栓塞失败时.
科学领域:
- 心脏病学 心脏病学
- 胸部外科手术 胸部外科手术
- 放射学 放射学是一门学科.
背景情况:
- 单侧肺动脉发生病 (UPAA) 是一种罕见的先天性疾病.
- UPAA可以呈现无症状或严重的血栓塞,复发性感染和支气管动脉缩.
- 系统性抵押流通通常与UPAA有关.
研究的目的:
- 突出UPAA患者血栓塞的诊断和管理挑战.
- 强调成像在确定UPAA作为导致血栓塞的原因中的作用.
- 讨论在UPAA中管理严重血所需的多学科方法.
主要方法:
- 对两名患有UPAA和严重血栓塞的患者的病例报告分析.
- 对诊断成像的审查,包括胸部CT扫描,以确定UPAA和相关的血管异常.
- 评估干预程序,如栓塞和手术干预,如肺切除术.
主要成果:
- 呈现了两例与UPAA相关的严重血栓塞.
- 尽管进行了多次栓塞尝试,但由于持续或复发性血栓塞,这两名患者都需要进行肺切除术.
- 在一个案例中,发现了支气管动脉缩和全身附带损伤,使管理复杂化.
结论:
- 在UPAA的背景下,血液溶解带来了重大管理挑战.
- 胸部CT扫描对于诊断患有血栓塞的患者的UPAA至关重要.
- 多学科的管理,通常需要手术干预,对于UPAA相关的血栓塞是至关重要的.
相关概念视频
01:30Pulmonary Hypertension: Classification and Pathogenesis
104
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
104
01:27Pneumothorax-II
104
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
104
01:21Acute Respiratory Failure-II
126
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
126
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
01:26Pneumothorax-I
154
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
154